Persistent overexpression of ET-1 results in vasoconstriction, endothelial dysfunction, neurohormonal overdrive, myocardial fibrosis, and adverse cardiac remodeling, thus favoring further disease progression and poor outcomes. This evidence concerns the gene EDN1 and endothelial dysfunction.